Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 27, 2014

Primary Completion Date

December 4, 2019

Study Completion Date

December 4, 2019

Conditions
Advanced Cancers
Interventions
DRUG

Fentanyl Buccal Tablet

Fentanyl buccal tablet given to put in between upper gum and cheek one hour after a six minute walk test.

OTHER

Placebo Buccal Tablet

Placebo buccal tablet given to put in between upper gum and cheek one hour after a six minute walk test.

BEHAVIORAL

Questionnaires

Completion of two questionnaires at beginning of study visit. It should take about 10 minutes to complete. At the end of study visit, completion of last questionnaire. It should take about 5 minutes to complete the questionnaire.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

Teva Pharmaceuticals USA

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER

NCT01856114 - Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea | Biotech Hunter | Biotech Hunter